» Articles » PMID: 15240637

Defective Liver Disposal of Free Fatty Acids in Patients with Impaired Glucose Tolerance

Overview
Specialty Endocrinology
Date 2004 Jul 9
PMID 15240637
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The liver exchanges high fluxes of glucose and free fatty acids (FFA) and is one main site of their reciprocal regulation. Acute exposure to hyperglycemia and hyperinsulinemia has been shown to reduce splanchnic beta-oxidation in healthy humans. We investigated whether a spontaneous condition of chronic mild hyperglycemia and hyperinsulinemia affects liver FFA uptake. Hepatic FFA influx rate constant (LKi) was measured after a 12-15-h fast in 10 patients with impaired glucose tolerance (IGT) and eight control subjects using positron emission tomography in combination with the long-chain FFA analog 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Compared with controls, IGT patients had higher serum insulin, glucose, and triglyceride levels (1.71 +/- 0.24 vs. 0.59 +/- 0.06 mmol/liter, P < 0.001), lower high-density lipoprotein (1.04 +/- 0.11 vs. 1.42 +/- 0.13 mmol/liter, P < 0.05), and similar FFA levels (0.59 +/- 0.06 vs. 0.56 +/- 0.05 mmol/liter(-1), P = not significant). LKi was significantly reduced in IGT (0.288 +/- 0.014 min(-1)) compared with control subjects (0.341 +/- 0.014 min(-1), P < 0.02). LKi was negatively correlated with plasma glucose (r = 0.51, P < 0.03), glycosylated hemoglobin (r = 0.55, P < 0.02), and blood lactate levels (r = 0.52, P < 0.03). We conclude that, in IGT patients, the ability of the liver to extract FFA from the circulation appears to be impaired. The reciprocal relationship between hepatic FFA extraction and glucose/lactate flux may derive from intrahepatic substrate competition.

Citing Articles

Labeled breath tests in patients with NASH: Octanoate oxidation relates best to measures of glucose metabolism.

Mucinski J, Perry A, Fordham T, Diaz-Arias A, Ibdah J, Rector R Front Physiol. 2023; 14:1172675.

PMID: 37153214 PMC: 10160408. DOI: 10.3389/fphys.2023.1172675.


The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease.

Grefhorst A, Van de Peppel I, Larsen L, Jonker J, Holleboom A Front Endocrinol (Lausanne). 2021; 11:601627.

PMID: 33597924 PMC: 7883485. DOI: 10.3389/fendo.2020.601627.


Quantitative PET of liver functions.

Keiding S, Sorensen M, Frisch K, Gormsen L, Munk O Am J Nucl Med Mol Imaging. 2018; 8(2):73-85.

PMID: 29755841 PMC: 5944823.


NAFLD and diabetes mellitus.

Tilg H, Moschen A, Roden M Nat Rev Gastroenterol Hepatol. 2016; 14(1):32-42.

PMID: 27729660 DOI: 10.1038/nrgastro.2016.147.


Membrane flexibility, free fatty acids, and the onset of vascular and neurological lesions in type 2 diabetes.

Weijers R J Diabetes Metab Disord. 2016; 15:13.

PMID: 27123439 PMC: 4847252. DOI: 10.1186/s40200-016-0235-9.